Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response. Each participant will be treated with 8 weeks of a luteinizing hormone-releasing hormone agonist (LHRHa) plus apalutamide (APA) while genome sequence characterization is being done. Participants with biopsy specimens deemed unevaluable for genomic testing will remain on LHRHa plus APA for an additional 16 weeks. Participa
Sponsor: University of British Columbia
Check if you qualify for this prostate cancer clinical trial in Seattle, WA
If you're searching for prostate cancer treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.